Lennart Nilsson1, Ágnes Csuth1, Jann Storsaeter2, Lene H Garvey3,4, Maria C Jenmalm5. 1. Department of Biomedical and Clinical Sciences, Allergy Center, Linköping University, Linköping. 2. Department of Vaccines, Public Health Agency of Sweden, Solna, Sweden. 3. Allergy Clinic, Department of Dermatology and Allergy, Copenhagen University Hospital Gentofte. 4. Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark. 5. Division of Inflammation and Infection, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
Abstract
PURPOSE OF REVIEW: Whereas the COVID-19 pandemic has changed our lives worldwide, we hope that vaccination can combat the disease. We propose how to evaluate suspected severe allergic reactions to the vaccines so that as many as possible may be safely vaccinated. RECENT FINDINGS: Rare cases of severe allergic reactions after COVID-19 vaccination have been observed, seemingly at a higher frequency than for other vaccines. Few excipients are likely to have caused these reactions. IgE-mediated reactions to polyethylene glycol (PEG) and its derivatives are the most suspected, albeit hitherto unproven, causes. We suggest to make a diagnosis based on skin tests with PEG and PEG derivatives and that these be considered in relation to the decisions required before the first and the second vaccine dose. A vaccine without these excipients is available, but published data about its side effects are limited. SUMMARY: The underlying immunological mechanisms of the rare severe allergic reactions to the COVID-19 vaccines are poorly understood and need to be clarified. Identifying those who have an undiagnosed allergy to PEG and PEG derivatives is crucial before vaccination, and these substances are found in laxatives, cosmetics and in 30% of all our medications today.
PURPOSE OF REVIEW: Whereas the COVID-19 pandemic has changed our lives worldwide, we hope that vaccination can combat the disease. We propose how to evaluate suspected severe allergic reactions to the vaccines so that as many as possible may be safely vaccinated. RECENT FINDINGS: Rare cases of severe allergic reactions after COVID-19 vaccination have been observed, seemingly at a higher frequency than for other vaccines. Few excipients are likely to have caused these reactions. IgE-mediated reactions to polyethylene glycol (PEG) and its derivatives are the most suspected, albeit hitherto unproven, causes. We suggest to make a diagnosis based on skin tests with PEG and PEG derivatives and that these be considered in relation to the decisions required before the first and the second vaccine dose. A vaccine without these excipients is available, but published data about its side effects are limited. SUMMARY: The underlying immunological mechanisms of the rare severe allergic reactions to the COVID-19 vaccines are poorly understood and need to be clarified. Identifying those who have an undiagnosed allergy to PEG and PEG derivatives is crucial before vaccination, and these substances are found in laxatives, cosmetics and in 30% of all our medications today.
Authors: Jan Romantowski; Jerzy Kruszewski; Oskar Solarski; Andrzej Bant; Andrzej Chciałowski; Ilona Pietrzyk; Patrycja Sańpruch; Aleksandra Górska; Marta Chełmińska; Agata Knurowska; Marika Gawinowska; Ewa Jassem; Marek Niedoszytko Journal: Clin Transl Allergy Date: 2022-05-17 Impact factor: 5.657
Authors: Charlotte G Mortz; Henrik F Kjaer; Trine H Rasmussen; Helene M Rasmussen; Lene Heise Garvey; Carsten Bindslev-Jensen Journal: Clin Transl Allergy Date: 2022-01-08 Impact factor: 5.871
Authors: Marina Labella; Jose Antonio Céspedes; Inmaculada Doña; Mohamed H Shamji; Ioana Agache; Cristobalina Mayorga; Maria José Torres Journal: Allergy Date: 2021-10-31 Impact factor: 14.710
Authors: Carla Toledo-Salinas; Selma Cecilia Scheffler-Mendoza; Lina Maria Castano-Jaramillo; José Antonio Ortega-Martell; Blanca Estela Del Rio-Navarro; Ana María Santibáñez-Copado; José Luis Díaz-Ortega; Raúl Baptista-Rosas; Paulina Sánchez-Novoa; Miguel García-Grimshaw; Sergio Iván Valdés-Ferrer; Gustavo Reyes-Terán; David Alejandro Mendoza-Hernández Journal: J Clin Immunol Date: 2022-08-17 Impact factor: 8.542